Stephen M. Carpenter

Stephen M. Carpenter

Auto-generated profile, based on publicly available information

Stephen M. Carpenter

Biomedical Sciences Training Program, Department of Pathology, Case Western Reserve University School of Medicine, Cleveland, OH, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 March 2014 in Nature Reviews Microbiology
Verified
Journal Article
Closed access
PDF file
CNCláudio Nunes-Alves
Cláudio Nunes-Alves
MBMatthew G. Booty
Matthew G. Booty
SCStephen M. Carpenter
Stephen M. Carpenter
PJPushpa Jayaraman
Pushpa Jayaraman
ARAlissa C. Rothchild
Alissa C. Rothchild
SBSamuel M. Behar
Samuel M. Behar

1 May 2004 in Journal of Neurophysiology
Verified
Journal Article
Closed access
PDF file
NONikolai Otmakhov
Nikolai Otmakhov
LKLena Khibnik
Lena Khibnik
NONonna Otmakhova
Nonna Otmakhova
SCStephen Carpenter
Stephen Carpenter
SRShervin Riahi
Shervin Riahi
JLJohn Lisman
John Lisman
Chemically induced long-term potentiation (cLTP) could potentially work by directly stimulating the biochemical machinery that underlies synaptic plasticity, bypassing the need for synaptic activation. Previous reports suggested that agents that raise cAMP concentration might have this capability. We examined the cLTP induced in acute slices by application of Sp-cAMPS or a combination of the adenylyl cyclase activator, forskolin, and the phosphodiesterase inhibitor, rolipram. Under our conditions, cLTP was induced but only if inhibition was reduced. We found that this form of cLTP was blocked by a N-methyl-d-aspartate receptor (NMDAR) antagonist and required the low-frequency test stimulation typically used to monitor the strength of synapses. Interestingly, similar LTP could be induced by lowering the Mg2+concentration of the ACSF during forskolin/rolipram or Sp-cAMPS application or even by just lowering Mg2+concentration alone. This LTP was also NMDAR dependent and required only a few (∼5) low-frequency stimuli for its induction. The finding that even low-frequency synaptic stimulation was sufficient for LTP induction indicates that a highly sensitized plasticity state was generated. The fact that some stimulation was required means that potentiation is probably restricted to the stimulated axons, limiting the usefulness of this form of cLTP. However, when similar experiments were conducted using slice cultures, potentiation occurred without test stimuli, probably because the CA3–CA1 connections are extensive and because presynaptic spontaneous activity is sufficient to fulfill the activity requirement. As in acute slices, the potentiation was blocked by an NMDAR antagonist. Our general conclusion is that the induction of LTP caused by elevating cAMP requires presynaptic activity and NMDA channel opening. The method of inducing cLTP in slice cultures will be useful when it is desirable to produce NMDAR-dependent LTP in a large fraction of synapses.

20 October 2004 in Journal of Neuroscience
Verified
Journal Article
Open access
PDF file
NONikolai Otmakhov
Nikolai Otmakhov
JTJung-Hwa Tao-Cheng
Jung-Hwa Tao-Cheng
SCStephen Carpenter
Stephen Carpenter
BABrent Asrican
Brent Asrican
ADAyse Dosemeci
Ayse Dosemeci
JLJohn Lisman
John Lisman
Calcium/calmodulin-dependent protein kinase II (CaMKII) is a leading candidate for a synaptic memory molecule because it is persistently activated after long-term potentiation (LTP) induction and because mutations that block this persistent activity prevent LTP and learning. Previous work showed that synaptic stimulation causes a rapidly reversible translocation of CaMKII to the synaptic region. We have now measured green fluorescent protein (GFP)-CaMKIIα translocation into synaptic spines during NMDA receptor-dependent chemical LTP (cLTP) and find that under these conditions, translocation is persistent. Using red fluorescent protein as a cell morphology marker, we found that there are two components of the persistent accumulation. cLTP produces a persistent increase in spine volume, and some of the increase in GFP-CaMKIIα is secondary to this volume change. In addition, cLTP results in a dramatic increase in the bound fraction of GFP-CaMKIIα in spines. To further study the bound pool, immunogold electron microscopy was used to measure CaMKIIα in the postsynaptic density (PSD), an important regulator of synaptic function. cLTP produced a persistent increase in the PSD-associated pool of CaMKIIα. These results are consistent with the hypothesis that CaMKIIα accumulation at synapses is a memory trace of past synaptic activity.

21 May 2018 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
JYJason D Yang
Jason D Yang
DMDaniel Mott
Daniel Mott
RSRujapak Sutiwisesak
Rujapak Sutiwisesak
YLYu-Jung Lu
Yu-Jung Lu
FRFiona Raso
Fiona Raso
SBSamuel M Behar
Samuel M Behar
Containment of Mycobacterium tuberculosis (Mtb) infection requires T cell recognition of infected macrophages. Mtb has evolved to tolerate, evade, and subvert host immunity. Despite a vigorous and sustained CD8+ T cell response during Mtb infection, CD8+ T cells make limited contribution to protection. Here, we ask whether the ability of Mtb-specific T cells to restrict Mtb growth is related to their capacity to recognize Mtb-infected macrophages. We derived CD8+ T cell lines that recognized the Mtb immunodominant epitope TB10.44−11 and compared them to CD4+ T cell lines that recognized Ag85b240-254 or ESAT63-17. While the CD4+ T cells recognized Mtb-infected macrophages and inhibited Mtb growth in vitro, the TB10.4-specific CD8+ T cells neither recognized Mtb-infected macrophages nor restricted Mtb growth. TB10.4-specific CD8+ T cells recognized macrophages infected with Listeria monocytogenes expressing TB10.4. However, over-expression of TB10.4 in Mtb did not confer recognition by TB10.4-specific CD8+ T cells. CD8+ T cells recognized macrophages pulsed with irradiated Mtb, indicating that macrophages can efficiently cross-present the TB10.4 protein and raising the possibility that viable bacilli might suppress cross-presentation. Importantly, polyclonal CD8+ T cells specific for Mtb antigens other than TB10.4 recognized Mtb-infected macrophages in a MHC-restricted manner. As TB10.4 elicits a dominant CD8+ T cell response that poorly recognizes Mtb-infected macrophages, we propose that TB10.4 acts as a decoy antigen. Moreover, it appears that this response overshadows subdominant CD8+ T cell response that can recognize Mtb-infected macrophages. The ability of Mtb to subvert the CD8+ T cell response may explain why CD8+ T cells make a disproportionately small contribution to host defense compared to CD4+ T cells. The selection of Mtb antigens for vaccines has focused on antigens that generate immunodominant responses. We propose that establishing whether vaccine-elicited, Mtb-specific T cells recognize Mtb-infected macrophages could be a useful criterion for preclinical vaccine development. Immunodominant antigens elicit a large majority of T cells during an infection, and it is presumed that these T cells go on to recognize infected cells. Immunodominant antigens produced by Mycobacterium tuberculosis (Mtb) have been incorporated into vaccines, but whether T cells specific for these antigens recognize Mtb-infected cells is inconsistent. One of these is TB10.4 (EsxH), and after aerosol infection in mice, up to 40% of lung CD8 T cells recognize TB10.4. Vaccination with TB10.44−11 peptide elicits a robust response and TB10.4-specific memory CD8 T cells develop. However, these mice are not protected against Mtb challenge. In trying to understand why this vaccine fails, we discovered that TB10.4-specific CD8 T cells do not recognize Mtb-infected macrophages in vitro. In contrast, under identical conditions, Ag85b-specific CD4 T cells recognize Mtb-infected macrophages and inhibit Mtb growth. In contrast, polyclonal CD4 and CD8 T cells from the lungs of infected mice recognize Mtb-infected macrophages, suggesting macrophages present antigens other than the immunodominant TB10.4 antigen. Thus, we conclude that TB10.4 is a decoy antigen that elicits a dominant CD8 T cell response that poorly recognizes Mtb-infected macrophages, and allows Mtb to evade CD8 immunity. Instead, this response may benefit Mtb by promoting inflammation. We propose that the poor ability of CD8 T cells to mediate protection might arise because the dominant T cells are unable to recognize infected macrophages. Identifying antigens that are presented by infected cells should be prioritized, as their inclusion in vaccines may enhance the expansion of T cells that mediate protection.

1 December 2014 in Seminars in Immunology
Verified
Journal Article
Closed access
SBSamuel M. Behar
Samuel M. Behar
SCStephen M. Carpenter
Stephen M. Carpenter
MBMatthew G. Booty
Matthew G. Booty
DBDaniel L. Barber
Daniel L. Barber
PJPushpa Jayaraman
Pushpa Jayaraman

7 November 2016 in Scientific Reports
Verified
Journal Article
Open access
MBMatthew G. Booty
Matthew G. Booty
PBPalmira Barreira-Silva
Palmira Barreira-Silva
SCStephen M. Carpenter
Stephen M. Carpenter
CNCláudio Nunes-Alves
Cláudio Nunes-Alves
MJMiye K. Jacques
Miye K. Jacques
SBSamuel M. Behar
Samuel M. Behar
IL-21 is produced predominantly by activated CD4+ T cells and has pleiotropic effects on immunity via the IL-21 receptor (IL-21R), a member of the common gamma chain (γc) cytokine receptor family. We show that IL-21 signaling plays a crucial role in T cell responses during Mycobacterium tuberculosis infection by augmenting CD8+ T cell priming, promoting T cell accumulation in the lungs, and enhancing T cell cytokine production. In the absence of IL-21 signaling, more CD4+ and CD8+ T cells in chronically infected mice express the T cell inhibitory molecules PD-1 and TIM-3. We correlate these immune alterations with increased susceptibility of IL-21R−/− mice, which have increased lung bacterial burden and earlier mortality compared to WT mice. Finally, to causally link the immune defects with host susceptibility, we use an adoptive transfer model to show that IL-21R−/− T cells transfer less protection than WT T cells. These results prove that IL-21 signaling has an intrinsic role in promoting the protective capacity of T cells. Thus, the net effect of IL-21 signaling is to enhance host resistance to M. tuberculosis. These data position IL-21 as a candidate biomarker of resistance to tuberculosis.